MENU
  • Our company
    • CEO message
    • Company profile
    • Mission
    • Origin of the company name
    • Corporate symbol and color
    • Team
  • Latest news
  • To investors
  • Contact
  • EnglishEnglish
    • 日本語日本語
    • EnglishEnglish
    • 中文 (中国)中文 (中国)

GEXVal

  • Our company
    • CEO message
    • Company profile
    • Mission
    • Origin of the company name
    • Corporate symbol and color
    • Team
  • Latest news
  • To investors
  • Contact
  • EnglishEnglish
    • 日本語日本語
    • EnglishEnglish
    • 中文 (中国)中文 (中国)

December 2018

  1. HOME
  2. December 2018
2018/12/7 / Last updated : 2019/4/26 wpmaster Latest news

GEXVal CEO Kato speaks in San Diego Trade Mission Panel Discussion

GEXVal Inc. December 7, 2018 GEXVal CEO Kato speaks in San Diego Trade Mission Panel Discussion GEXVal Preside […]

Recent posts

Article by GEXVal titled “Rare-disease Drugs via Drug Repositioning” published in Medical Science Digest

2019/11/28

GEXVal Featured in Nikkan Kogyo Shimbun

2019/9/19

GEXVal Featured in Nikkan Kogyo Shimbun

2019/9/10

GEXVal mentioned in Nikkan Kogyo Shimbun

2019/8/29

EXVal Participates in “Venture Innovation Pavilion”

2019/7/1

Scrip Interviews: GEXVal Focuses On Rare Diseases As It Builds On Ex-Takeda Assets

2019/6/4

GEXVal participates in CHINABIO PARTNERINGFURUM 2019

2019/4/26

GEXVal Appeared in Nikkei, Japan’s Largest Financial Paper

2019/4/22

GEXVal participated in the 139th Annual Meeting of the Pharmaceutical Society of Japan

2019/3/20

GEXVal gives presentation at BIO-Asia 2019

2019/1/19

Category

  • IR
  • Latest news

Archive

  • November 2019
  • September 2019
  • August 2019
  • July 2019
  • June 2019
  • April 2019
  • March 2019
  • January 2019
  • December 2018
  • November 2018
  • October 2018
  • September 2018
  • August 2018
  • June 2018

Copyright © GEXValAll Rights Reserved.